What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?
- 1 January 1997
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 7 (1) , 42-45
- https://doi.org/10.1046/j.1525-1438.1997.00422.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- An Assessment of the Value of Serum CA 125 Measurements in the Management of Epithelial Ovarian CarcinomaGynecologic Oncology, 1994
- CA125 Measurement in Epithelial Ovarian Cancer: A 10-Year Anniversary of Clinical InvestigationGynecologic Oncology, 1993
- Prognostic value of CA 125 in advanced ovarian cancerGynecologic Oncology, 1992
- Correlation of abdominal ultrasound and computed tomography scans with second- or third-look laparotomy in patients with ovarian carcinomaGynecologic Oncology, 1990
- The prognostic significance of the half‐life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinomaBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1989
- Ovarian cancer: The prognostic value of the serum half-life of CA125 during induction chemotherapyGynecologic Oncology, 1988
- CA125 Serum Levels and Secondary Laparotomy in Epithelial Ovarian TumoursAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1987
- A critical reassessment of second-look laparotomy in epithelial ovarian carcinomaCancer, 1986
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981